Prostatespecific membrane antigen PET-CT in patients with highrisk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study - Hofman, M S; Lawrentschuk, N; Francis, R J (Lancet, 2020)